Medicine
Vraylar 4.5 mg capsule
Vraylar 4.5 mg capsule is a prescription medicine containing Cariprazine for oral use, marketed by Allergan, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20ºC to 25°C (68ºF to 77°F), excursions permitted between 15°C and…
Key facts
- Active ingredient (INN)
- Cariprazine
- Brand
- Vraylar
- Strength
- 4.5 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 30 capsules
- Marketing authorisation holder
- Allergan
- Manufacturer
- Allergan
- Origin register
- US FDA, United States
- Storage
- Store at 20ºC to 25°C (68ºF to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AX15 Cariprazine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 September 2015
- Identifiers
- RxCUI 1667660, 1667666, 1667668 +7DailyMed set ID 4b5f7c65-aa2d-452a-b3db-bc85c06ff12fNDC 61874-145Application NDA204370
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 capsule, gelatin coated in 1 bottle | 61874-145-30 | Allergan | 1 March 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cariprazine
Clinical summary
Cariprazine is an atypical antipsychotic indicated for treatment of schizophrenia in adult and pediatric patients 13 years of age and older, among other approved uses. It is available as capsules and kits for oral use. MedsAcross supplies Cariprazine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CariprazineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Vraylar prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
- Reagila: European public assessment report (EPAR) · European Medicines Agency
Need Vraylar 4.5 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.